Denmark: health system review

This analysis of the Danish health system reviews recent developments in organization and governance, health financing, health care provision, health reforms and health system performance. Population health in Denmark isgood and improving, with life expectancy above the European Union average but is, however, lagging behind the other Nordic countries. Denmark has a universal and tax-financed health system, providing coverage for acomprehensive package of health services. Notable exclusions to the benefits package include outpatient prescription drugs and adult dental care, which require co-payment and are the main causes of out-of-pocket spending. The hospital sector has been transformed during the past 15 years through a process of consolidating hospitals and the centralization of medical specialties. However, in recent years, there has been a move towards decentralization to increase the volume and quality of care provided outside hospitals in primary and local care settings. The Danish health care system is, to a very high degree, based on digital solutions that health care providers, citizens and institutions all use. Ensuring the availability of health care in all parts of Denmark is increasingly seen as a priority issue.Ensuring sufficient health workers, especially nurses, poses a significant challenge to the Danish health system’s sustainability and resilience. While a comprehensive package of policies has been put in place to increase thenumber of nurses being trained and retain those already working in the system, such measures need time to work. Addressing staffing shortages requires long-term action. Profound changes in working practices and workingenvironments will be required to ensure the sustainability of the health workforce and, by extension, the health system into the future.

Trust and transformation: resilient and sustainable health systems for the future: meeting report of the Tallinn Charter 15th Anniversary Health Systems Conference, 12–13 December 2023, Tallinn, Estonia

In Tallinn, Estonia, on 12–13 December 2023, the Ministry of Social Affairs of the Republic of Estonia and the WHO Regional Office for Europe co‑hosted a high-level health systems conference to commemorate 15 years of the Tallinn Charter: Health Systems for Health and Wealth. Building on the values of the Charter and the theme of subsequent conferences commemorating its signing, the 15th Anniversary Health Systems Conference was held under the theme “Trust and transformation: resilient and sustainable health systems for the future”. This report describes what happened during the conference and presents the main messages shared during each of its sessions. The policy briefs, full-length films supporting the case study sessions, the conference outcome statement and other related documents can be accessed via the conference webpage (“Tallinn Charter 15th Anniversary Health Systems Conference: trust and transformation: resilient and sustainable health systems for the future”).

Strengthening Health Systems: A Practical Handbook for Resilience Testing

This handbook helps health system actors (leaders, managers, providers and payers) assess how vulnerable their health system is to a shock, pinpoint the kinds of actions needed to make it resilient and begin to develop responses to protect it.

Denmark: Health System Summary, 2024

This Health system summary is based on the Denmark: Health System Review published in 2024 in the Health Systems in Transition (HiT) Series. Health system summaries use a concise format to communicate central features of country health systems and analyse available evidence on the organization, financing and delivery of health care. They also provide insights into key reforms and the varied challenges testing the performance of the health system.

Estonia: Health System Summary, 2024

This Health System Summary is based on the Estonia: Health System Review published in 2023 in the Health Systems in Transition (HiT) series. Health System Summaries use a concise format to communicate central features of country health systems and analyse available evidence on the organization, financing and delivery of health care. They also provide insights into key reforms and the varied challenges testing the performance of the health system.

Belgium: Health System Summary, 2024

This Health system summary is based on the Belgium: Health System Review published in 2020 in the Health Systems in Transition (HiT) series but is significantly updated, including data, policy developments and relevant reforms as highlighted by the Health Systems and Policies Monitor (HSPM) (www.hspm.org). For this summary, key data have been updated to those available in September 2023 unless otherwise stated. Health system summaries use a concise format to communicate central features of country health systems and analyse available evidence on the organization, financing and delivery of health care. They also provide insights into key reforms and the varied challenges testing the performance of the health system.

France: Health System Summary, 2024

This Health system summary is based on the France Health System Review published in 2023 in the Health Systems in Transition (HiT) series. Health system summaries use a concise format to communicate central features of country health systems and analyse available evidence on the organization, financing and delivery of health care. They also provide insights into key reforms and the varied challenges testing the performance of the health system.

Отчет о результатах консультаций с государствами-членами, организациями-партнерами и негосударственными структурами по созданию Платформы обеспечения доступа к новым лекарственным средствам: январь – февраль 2023 г.: резюме

Европейская программа работы ВОЗ на 2020–2025 гг. «Совместные действия для улучшения здоровья жителей Европы» (ЕПР) выдвигает на передний план важность обеспечения социально справедливого и устойчивого доступа к качественным лекарственным средствам для достижения всеобщего охвата услугами здравоохранения и Целей в области устойчивого развития (ЦУР). Вопросы доступа к лекарственным средствам и изделиям медицинского назначения неизбежно возникают на стыке постановки трех задач ЦУР, а именно: ЦУР 3 – содействовать повышению уровня здоровья и благополучия; ЦУР 9 – развивать промышленность и инфраструктуру и поощрять инновации; и ЦУР 17 – активизировать партнерства ради достижения поставленных Целей.